Respecting autonomy—a call for truth in commercial advertising for planned oocyte cryopreservation
Volume 113, Issue 4, Pages 743–744
Michelle J. Bayefsky, B.A.a, Alan H. DeCherney, M.D.b, Louise P. King, M.D., J.D.c,d
Over the past decade, the number of women undergoing planned oocyte cryopreservation (pOC) has risen dramatically. According to the Society for Assisted Reproductive Technology, 475 women underwent pOC in 2009 and 9,042 in 2017. The demographics of women choosing pOC have also shifted; in 2009, 47% were under 38, whereas in 2017, 64% were under 38 years of age. The decision to freeze eggs for nonmedical reasons may seem empowering to some, but if women choose pOC because of an inaccurate perception of the promises of the technology, power may actually have been compromised.